Class Action Lawsuit on behalf of certain investors in Immucor, Inc. (Public, NASDAQ:BLUD) over alleged securities laws violations by Immucor – Deadline: October 23, 2009 – Contact the Shareholders Foundation, Inc. at mail@shareholdersfoundation.com
An investor in Immucor, Inc. (Public, NASDAQ:BLUD) has filed a lawsuit in the United States District Court for the Northern District of Georgia on behalf of purchasers of Immucor, Inc. (NASDAQ:BLUD) publicly traded securities during the period between October 19, 2005 and April 23, 2009, against Immucor and others over alleged violations of Federal Securities Laws.
If you purchased Immucor, Inc. (NASDAQ:BLUD) publicly traded securities during the period between October 19, 2005 and April 23, 2009, you have certain options and there are strict and short deadlines running. Deadline: October 23, 2009. Those BLUD investors and current long term investors should contact the Shareholders Foundation, Inc. at:
According to the complaint the plaintiff alleges that Immucor and certain of its officers and directors violated the Securities Exchange Act of 1934 by failing to disclose that Immucor was operating in violation of the federal antitrust laws of the United States. The plaintiff accuses that between October 19, 2005 and April 23, 2009 the defendants materially misrepresented Immucor’s business operations. On April 24, 2009, Immucor issued a press release, which stated in part: “Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it received a subpoena from the United States Department of Justice, Antitrust Division, requesting documents for the period beginning September 1, 2000 through the present, pertaining to an investigation of possible violations of the federal criminal antitrust laws in the blood reagents industry. Immucor intends to fully cooperate with the investigation.”
As a result of this disclosure, Immucor’s closing stock price dropped from $20.98 on April 23, 2009 to $15.35 the next trading day, so the lawsuit.
The plaintiff accuses that this decrease in Immucor’s stock price was a result of the artificial inflation caused by defendants’ misleading statements coming out of the stock price.
Immucor, Inc, located in Norcross, GA, develops, manufactures and sells a line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. Immucor, Inc reported in 2007 (ending on May 31, 2008) Total Revenue of 261.20million with a Net Income of $71.45million and in 2008 (ending on May 31, 2009) Total Revenue of $300.55million with a Net Income of $76.18million. Immucor, Inc shares (NASDAQ: BLUD) recently traded at $18.47 per share, down from a 52weekHigh of $33.80 per share and almost $40 per share in 2007.
Those who purchased Immucor, Inc. (NASDAQ:BLUD) publicly traded securities during the period between October 19, 2005 and April 23, 2009, have certain options and there are strict and short deadlines running. Deadline: October 23, 2009. Those BLUD investors and current long term investors should contact the Shareholders Foundation, Inc. at:
Shareholders Foundation, Inc.
Trevor Allen
3111 Camino Del Rio North - Suite 423 -
92108 San Diego
Tel:+1-(858)-779-1554
Fax:+1-(858)-605-5739 mail@shareholdersfoundation.com www.ShareholdersFoundation.com
_____________________________________________________________________________________
Advertising. The Shareholders Foundation, Inc. is an investor advocacy group. We do research related to shareholder issues and inform investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. At Shareholders Foundation, Inc. we are in contact with a large number of shareholders. We believe that together we can combine the interests of many investors, and use the size of our interest as leverage against the giant corporations. We offer help, support, and assistance for every shareholder. We help investors find answers to their questions and equitable solutions to their problems. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
